STERIS plc vs Eli Lilly & Co.
STE vs LLY — side-by-side comparison from reported financials. STE leads 4, LLY leads 8 of 12 comparable metrics.
STERIS plc
STE · Healthcare
$214.40+1.73%Strong
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | STE | LLY |
|---|---|---|
| Price | $214.40 | $1 177.20 |
| Market cap | $20.9B | $1.05T |
| Revenue (TTM) | $6.04B | $79.7B |
| Revenue growth | +6.2% | +31.7% |
| Net margin | 13.3% | 33.5% |
| Free cash flow | $926M | $18.2B |
| Net cash (debt) | ($1.65B) | ($35.2B) |
| 1-year price return | -10.5% | +37.6% |
| P/E | 26.0 | 41.6 |
| P/E vs own history (cheap-side %) | 97% | 88% |
| Dividend yield | 1.18% | 0.52% |
| Return on equity | 11% | 93% |
| Altman Z-score | 4.34 | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 17,937 | 50,000 |
Full résumé-style profiles: STE CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.